ADM loses faith in bioplastic JV on cost and demand anxieties
Archer Daniels Midland (ADM) said it is considering the future of its bioplastics operations as it terminated its joint venture with Metabolix and prepared to halt production of the PHA resin at the purpose-built US facility.